Skip to main content

 ANC: Neuroscience of Disease


Panteleimon Giannakopoulos, PhD, University of Geneva, Switzerland
Jason Huse, University of Texas MD Anderson Cancer Center, USA

Aims and scope

Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques

Call for Papers: Investigating the Biology of Brain Metastases

This Collection aims to bring together the latest research on brain metastases biology.

Read More

Call for Papers: Neuropathology and Neurodegeneration in the Retina

This Collection will highlight basic, translational, and clinical studies that address current knowledge gaps in retinal neurodegenerations.

Read More

Why publish with ANC?

  • No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
  • Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
  • Rapid publication: publication within 2 months of submission
  • Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
  • Open access: enabling it to be read by a much larger set of readers, increasing its visibility
  • Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees


Our Commitment to excellent author service

ANC is committed to rapid publication. We aim to publish all research articles within 2 months of submission, subject to authors responding to requests within the required timeframe. For further information, please read our FAQs.

Sister journal

ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.

Read more here

From the Editors-in-Chief

"The definition of the molecular and cellular background as well as pathogenetic pathways of neurological and psychiatric disorders is a major challenge of modern medicine. Neuropathology moves quickly from classical studies on histological characteristics of neurodegenerative, neurodevelopmental and mental disorders to the integration of complex models that include proteomics, transcriptomics and single cell analyses coupled with ad hoc behavioral investigations in animal models and humans. Acta Neuropathologica Communications provides a unique platform for rapidly published reports that involve clinical and experimental neuropathology. The broad scope of the journal covers clinical investigations in human samples, animal and in vitro studies on the molecular phenotypes but also reports on the complex interplay between environmental stressors, epigenetic regulation and cellular expression in neuropsychiatric diseases. Excellent papers that provide key contributions on the pathogenesis of brain pathologies are warmly welcome. We guarantee high quality reviews and fast publication that makes it possible to be at the cutting edge of scientific efforts in this challenging field. I look forward to receive your work!"

Panteleimon Giannakopoulos, co-Editor-in-Chief, ANC

"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand.  ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead." 

Jason T. Huse, co-Editor-in-Chief, ANC

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 6.2
    5-year Journal Impact Factor: 6.8
    Source Normalized Impact per Paper (SNIP): 1.344
    SCImago Journal Rank (SJR): 2.580

    Speed 2023
    Submission to first editorial decision (median days): 3
    Submission to acceptance (median days): 50

    Usage 2023
    Downloads: 1,631,164
    Altmetric mentions: 3,652